MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ADXN Addex Therapeutics
- 7.9000
- +0.0400+0.51%
Close Dec 20 16:00 ET
8.44MMarket Cap2.94P/E (TTM)
7.9000High7.8400Low12.11KVolume7.8400Open7.8600Pre Close95.13KTurnover2.26%Turnover RatioLossP/E (Static)1.07MShares27.900052wk High0.68P/B4.23MFloat Cap5.900052wk Low--Dividend TTM535.12KShs Float750.4000Historical High--Div YieldTTM0.76%Amplitude5.0000Historical Low7.8550Avg Price1Lot Size
About Addex Therapeutics Company
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Company Profile
SymbolADXN
Company NameAddex Therapeutics
Listing DateJan 29, 2020
Founded2002
CEOMr. Tim Dyer
MarketNASDAQ
Employees23
Securities TypeDR
ADS Ratio1.0 : 120.0
Fiscal Year Ends12-31
Address9, Chemin des Mines,Plan-les-Ouates
CityGeneva
ProvinceGeneve (Geneva)
CountrySwitzerland
Zip Code1202
Phone41-22-884-15-55
Company Executives
- Name
- Position
- Salary
- Tim Dyer
- Chief Executive Officer and Director
- --
- Dr. Roger M. Mills,M.D.
- Chief Medical Officer and Director
- --
- Vincent Lawton
- Chairman of the Board
- 155.75K
- Raymond Hill
- Director
- 89.65K
- Jake R. Nunn
- Independent Director
- 41.29K
- Dr. Isaac Manke
- Independent Director
- 41.29K
- Lénaic Teyssédou
- Head of Finance
- --
- Jean-Philippe Rocher
- Head of Discovery, Chemistry
- --
- Dr. Mikhail Kalinichev
- Head of Translational Science
- --
- Robert Lütjens
- Head of Discovery, Biology
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.